TLRY, CGC stocks lead rally in marijuana stocks as legalization hopes return (NASDAQ:TLRY)Posted by On

cannabis legalization in the united states of america. cannabis leaf in hands on usa flag background

strelov/iStock via Getty Images

Canadian cannabis names lead a rebound in pot stocks in early trading as they extend gains on Friday in reaction to an upcoming House vote to legalize marijuana in the U.S.

The stocks turned higher near the market close Thursday on the news that the U.S. House of Representatives would take up the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act on Monday. Sponsored by House Judiciary Committee Chairman Jerrold Nadler (D-NY), the bill, among others, aims to remove cannabis from the list of federally controlled substances.

Notable gainers in the pre-market include Tilray (NASDAQ:TLRY), Canopy Growth (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Sundial Growers (NASDAQ:SNDL), and HEXO (HEXO), with gains exceeding 10%. Other Canadian names, including Cronos Group (CRON) and OrganiGram Holdings (OGI), are also trading higher.

A previous version of the bill cleared the House floor but stalled on the Senate shortly after the federal election in 2020. The latest attempt comes ahead of the November midterm elections.

Last November, pot stocks led by U.S. Multi-State Operators rallied in reaction to a similar bill sponsored by Republican congresswoman Nancy Mace (R-SC). The States Reform Act has yet to receive a hearing in Congress.

However, the U.S. MSOs and Canadian LPs ended the year lower as legalization hopes fizzled. And they continue to underperform the broader maker for the past 12 months, as shown in this graph.

Original Author Link click here to read complete story..

cannabis legalization in the united states of america. cannabis leaf in hands on usa flag background

strelov/iStock via Getty Images

Canadian cannabis names lead a rebound in pot stocks in early trading as they extend gains on Friday in reaction to an upcoming House vote to legalize marijuana in the U.S.

The stocks turned higher near the market close Thursday on the news that the U.S. House of Representatives would take up the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act on Monday. Sponsored by House Judiciary Committee Chairman Jerrold Nadler (D-NY), the bill, among others, aims to remove cannabis from the list of federally controlled substances.

Notable gainers in the pre-market include Tilray (NASDAQ:TLRY), Canopy Growth (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Sundial Growers (NASDAQ:SNDL), and HEXO (HEXO), with gains exceeding 10%. Other Canadian names, including Cronos Group (CRON) and OrganiGram Holdings (OGI), are also trading higher.

A previous version of the bill cleared the House floor but stalled on the Senate shortly after the federal election in 2020. The latest attempt comes ahead of the November midterm elections.

Last November, pot stocks led by U.S. Multi-State Operators rallied in reaction to a similar bill sponsored by Republican congresswoman Nancy Mace (R-SC). The States Reform Act has yet to receive a hearing in Congress.

However, the U.S. MSOs and Canadian LPs ended the year lower as legalization hopes fizzled. And they continue to underperform the broader maker for the past 12 months, as shown in this graph.



Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.